Guselkumab Biosimilar - Anti-IL23A mAb - Research Grade
Source
CAS 1350289-85-8
Species
Homo sapiens
Expression system
Mammalian cells
Molecular weight
143kDa
Purity
>85%
Buffer
PBS buffer PH7.5
Delivery condition
Blue ice (+4°C)
Delivery Time
3-5 days if in stock; 3-5 weeks if production needed
Storage condition
store at -80°C
Brand
ProteoGenix
Aliases /Synonyms
Guselkumab,CNTO-1959,IL23A,anti-IL23A
Reference
PX-TA1327
Note
For research use only. Not suitable for clinical or therapeutic use.
Isotype
IgG1-lambda
Clonality
Monoclonal Antibody
Description of Guselkumab Biosimilar - Anti-IL23A mAb - Research Grade
General information on Anti-IL23A[Homo sapiens] (Guselkumab) Monoclonal Antibody
Guselkumab is a human IgG1 lambda monoclonal antibody that targets interleukin-23. IL-23 is an inflammatory cytokine that is reponsible for the activation of the CD4+ T-helper (Th17) cell pathway in the inflammatory cascade that induces psoriatic plaque formation. Guselkumab has been used to treat psoriasis. It has been sold under the trade name Tremfya.
SDS-PAGE for Guselkumab Biosimilar - Anti-IL23A mAb
Guselkumab Biosimilar - Anti-IL23A mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Reviews
There are no reviews yet.
REVIEW YOUR PRODUCT
Be the first to review “Guselkumab Biosimilar – Anti-IL23A mAb – Research Grade” Cancel reply
Reviews
There are no reviews yet.